Company Search:
Advanced Search
Sponsored Links
Cellumed Co Ltd Company Snapshot
Cellumed Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cellumed Co Ltd with three other companies in this sector in South Korea: ISU Abxis Company Limited (2015 sales of 11.47 billion Korean Won [US$10.20 million] of which 100% was Antibody Medicine), Corestem Inc (18.57 billion Korean Won [US$16.51 million] of which 78% was The clinical trial agent), and Viromed Company Ltd (7.70 billion Korean Won [US$6.84 million] ).

Sales Analysis. Cellumed Co Ltd reported sales of 17.73 billion Korean Won (US$15.76 million) for the year ending December of 2015. This represents a decrease of 14.5% versus 2014, when the company's sales were 20.73 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cellumed Co Ltd
  Stock Performance Chart for Cellumed Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 2,140.00
(Figures in Korean Won)
1 Week -7.4%   13 Weeks 1.2%  
4 Weeks -14.4%   52 Weeks 196.4%  
Cellumed Co Ltd Key Data:
  Ticker: 049180 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 17,730,838,347
(Year Ending Jan 2016).
Employees: 106
  Currency: Korean Won Market Cap: 370,256,694,580
  Fiscal Yr Ends: December Shares Outstanding: 173,017,147
  Share Type: Common Closely Held Shares: 7,430,335
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.